WO2025202937 - CANCER VACCINES
National phase entry is expected:
Publication Number
WO/2025/202937
Publication Date
02.10.2025
International Application No.
PCT/IB2025/053207
International Filing Date
26.03.2025
Title **
[English]
CANCER VACCINES
[French]
VACCINS ANTICANCÉREUX
Applicants **
BIONTECH SE
Inventors
SAHIN, Ugur
Priority Data
63/570,183
26.03.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 6522 | |
| EPO | Filing, Examination, Granting | 105554 | |
| Japan | Filing, Examination, Granting | 4812 | |
| South Korea | Filing, Examination, Granting | 7818 | |
| USA | Filing, Examination, Granting | 29340 |
Total:
154,046
Contact Us
Abstract[English]
The present disclosure provides compositions (e.g., pharmaceutical compositions) for delivery of shared tumor antigen epitopes and neoantigen epitopes, and related technologies (e.g., components thereof and/or methods relating thereto). Among other things, the present disclosure provides polyribonucleotides encoding polyepitopic vaccines including shared tumor antigen epitopes and polyribonucleotides encoding polyepitopic vaccines including neoantigen epitopes.[French]
La présente divulgation concerne des compositions (par exemple, des compositions pharmaceutiques) pour l'administration d'épitopes d'antigènes tumoraux partagés et d'épitopes néoantigènes, et des technologies associées (par exemple, des composants de celles-ci et/ou des procédés s'y rapportant). Entre autres, la présente divulgation concerne des polyribonucléotides codant pour des vaccins polyépitopiques comprenant des épitopes d'antigènes tumoraux partagés et des polyribonucléotides codant pour des vaccins polyépitopiques comprenant des épitopes néoantigènes.